换一批Pharmacokinetic-pharmacodynamic modelling of platelet response to ticagrelor in stable coronary artery disease and prior myocardial infarction patients.
第一作者：
Magnus,Åstrand
第一单位：
Early Clinical Development, IMED Biotech Unit, AstraZeneca, Gothenburg, Sweden.
作者：
医学主题词
成年人(Adult);老年人(Aged);老年人, 80以上(Aged, 80 and over);血小板(Blood Platelets);临床试验, Ⅱ期(主题)(Clinical Trials, Phase II as Topic);临床试验, Ⅲ期(主题)(Clinical Trials, Phase III as Topic);冠状动脉疾病(Coronary Artery Disease);剂量效应关系, 药物(Dose-Response Relationship, Drug);用药计划表(Drug Administration Schedule);女(雌)性(Female);人类(Humans);男(雄)性(Male);中年人(Middle Aged);模型, 生物学(Models, Biological);多中心研究(主题)(Multicenter Studies as Topic);心肌梗死(Myocardial Infarction);血小板聚集(Platelet Aggregation);血小板功能试验(Platelet Function Tests);嘌呤能P2Y受体拮抗剂(Purinergic P2Y Receptor Antagonists);随机对照试验(主题)(Randomized Controlled Trials as Topic);治疗结果(Treatment Outcome);青年人(Young Adult)
DOI
10.1111/bcp.13812
PMID
30414387
发布时间
2021-01-09
- 浏览11
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
